{"schema_version":"secwatch.filing_event.v1","accession":"0001779372-23-000019","form_type":"8-K","ticker":"BEAT","cik":"0001779372","company_name":"HeartBeam, Inc.","filed_at":"2023-07-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.196512+00:00","generated_at":"2026-06-13T02:25:14.605314+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"HeartBeam appoints Dr. Michael R. Jaff to board effective July 24, 2023","bullets":["Board size increased to 8 directors to accommodate appointment of Dr. Jaff.","Dr. Jaff is CMO and VP at Boston Scientific; former Harvard professor and hospital president.","He is founder of VasCore and Past-President of the Society for Vascular Medicine.","No family relationships or related party transactions reported with the new director.","Press release announcing appointment issued on July 26, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001779372-23-000019","json":"https://secwatch.observer/filing/0001779372-23-000019.json","markdown":"https://secwatch.observer/filing/0001779372-23-000019.md","text":"https://secwatch.observer/filing/0001779372-23-000019.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1779372/000177937223000019/0001779372-23-000019-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1779372/000177937223000019/beat-20230724.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T02:25:14.605314+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"df4418ae93","claim":"Michael R. Jaff was appointed as director at HeartBeam, Inc..","evidence_excerpt":"On July 24, 2023, the Board of Directors (the “Board”) of HeartBeam, Inc. (the “Company”) approved the appointment of Michael R. Jaff as a director of the Company (the “Appointment”) effective as of July 24, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1779372/000177937223000019/0001779372-23-000019-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}